Excluding Excise Duty and Other Income, represents Net Revenue
Sequent Scientific Ltd revenue growth forecast
Expected growth rate Q1, FY2022:2.45%
Forecast
Actual
Including amortisation and stock based compensations
Sequent Scientific Ltd EPS growth forecast
EPS estimate Q1, FY2022:
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 14.16 % |
3 Month Return | + 21.14 % |
1 Year Return | + 70.97 % |
Market Stats | |
Previous Close | ₹192.57 |
Open | ₹192.00 |
Volume | 2.83L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,807.36Cr |
P/E Ratio | 306.2 |
PEG Ratio | 46.89 |
Market Cap | ₹4,807.36 Cr |
P/B Ratio | 2.65 |
EPS | -1.19 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0.22 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹4,807.36 Cr | 40.19% | 0.52 | -₹30 Cr | ₹1,369 Cr | |
NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
Organisation | Sequent Scientific Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Sequent Scientific Ltd
Sequent Scientific has successfully acquired full ownership of N-VET AB in Sweden and Alivira Italia SRL in Italy, enhancing its operational control and market presence in animal healthcare.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, SEQUENT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
Foreign Institutions have increased holdings from 5.70% to 6.45% in Sep 2024 quarter
Price Rise
In the last 7 days, SEQUENT stock has moved up by 8.2%
MF Holding Up
Mutual Funds have increased holdings from 5.69% to 7.41% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 116.2%
Profit Down
Netprofit is down for the last 2 quarters, 6.51 Cr → 2.61 Cr (in ₹), with an average decrease of 59.9% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 392.89 Cr → 373.16 Cr (in ₹), with an average decrease of 5.0% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 33.30% to 30.63% in Sep 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 52.78% to 52.76% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 52.76% | ||
Foreign Institutions | 6.45% | 13.21 | |
Mutual Funds | 7.41% | 30.35 | |
Retail Investors | 30.63% | ||
Others | 2.75% | 8.19 |
Sequent Scientific Ltd in the last 5 years
Lowest (-117.80x)
January 17, 2023
Industry (54.77x)
November 22, 2024
Today (306.20x)
November 22, 2024
Highest (1034.67x)
September 27, 2024
Sequent Scientific Ltd’s net profit jumped 131.15% since last year same period to ₹2.61Cr in the Q2 2024-2025. On a quarterly growth basis, Sequent Scientific Ltd has generated -59.91% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2021, Sequent Scientific Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.25%.
Read More about DividendsBearish
Neutral
Bullish
Sequent Scientific Ltd is currently in a Bullish trading position according to technical analysis indicators.
Sequent Scientific Ltd (SEQUENT) share price today is ₹202.09
Sequent Scientific Ltd is listed on NSE
Sequent Scientific Ltd is listed on BSE
PE Ratio of Sequent Scientific Ltd is 306.2
PE ratio = Sequent Scientific Ltd Market price per share / Sequent Scientific Ltd Earnings per share
Today’s traded volume of Sequent Scientific Ltd(SEQUENT) is 2.83L.
Today’s market capitalisation of Sequent Scientific Ltd(SEQUENT) is ₹4807.36Cr.
Sequent Scientific Ltd(SEQUENT | Price |
---|---|
52 Week High | ₹240.7 |
52 Week Low | ₹92.05 |
Sequent Scientific Ltd(SEQUENT) share price is ₹202.09. It is down -16.04% from its 52 Week High price of ₹240.7
Sequent Scientific Ltd(SEQUENT) share price is ₹202.09. It is up 119.54% from its 52 Week Low price of ₹92.05
Sequent Scientific Ltd(SEQUENT | Returns |
---|---|
1 Day Returns | 9.52% |
1 Month Returns | 14.16% |
3 Month Returns | 21.14% |
1 Year Returns | 70.97% |